A PhD in chemiluminescence, a scientific research elite, he has been deeply involved in the field of in vitro diagnostics for more than ten years and has an excellent industry background. He has worked in many leading IVD companies as a senior R&D director, independently developed more than 40 chemiluminescence projects, and led the team to obtain more than 100 medical device registration certificates.

a senior expert in the field of molecular diagnostics and a Doctor of Clinical Laboratory Diagnostics, has over ten years of experience in the in vitro diagnostic (IVD) industry and clinical laboratory practice. He is proficient in core molecular diagnostic technologies such as quantitative real-time PCR, digital PCR, and gene sequencing, familiar with global IVD product registration regulations including NMPA/FDA/CE, and possesses end-to-end capabilities covering technology R&D, product transformation, and team management. During his career, he led the R&D of multiple molecular diagnostic kits for COVID-19, respiratory pathogens, etc., among which 8 have been certified by NMPA, with cumulative sales exceeding 200 million yuan. Meanwhile, he deeply participated in the construction of quality systems for molecular diagnostic laboratories at the clinical end, completing more than 10,000 tumor-related gene tests to provide key technical support for clinical precision diagnosis and treatment as well as IVD product innovation.

a senior expert in the immunohistochemistry (IHC) field of the IVD industry, has over ten years of frontline and management experience in the IVD industry, as well as IHC reagent R&D, pathological testing technology application, and product transformation. He is proficient in core skills such as IHC reagent formula R&D and optimization, antibody labeling and screening, and IHC-ISH combined detection technology, and focuses on the adaptation verification of IHC products with clinical pathology laboratory processes. Under his leadership, the performance of multiple histochemical detection reagents developed by his team has exceeded that of imported reagents, with cumulative sales of related products exceeding 100 million yuan.

a senior expert in the biochemical testing field of the IVD industry, has over twenty years of frontline and management experience in the IVD industry and clinical biochemical testing. He is proficient in core biochemical testing technologies such as automatic biochemical analysis system operation and optimization, colorimetry/turbidimetry/enzyme-catalyzed reactions, focuses on biochemical reagent formula R&D and performance verification, and is familiar with global IVD product registration regulations including NMPA/FDA/CE and clinical laboratory quality control standards. He holds core capabilities in biochemical testing technology R&D, reagent product transformation, and team overall management.

a senior expert in the microfluidics field of the IVD industry, has years of frontline and management experience in the IVD industry, as well as microfluidic chip R&D and product transformation. He is proficient in core technologies such as microfluidic chip design and simulation, microchannel structure optimization, and microfluidic control, and focuses on the R&D of compatibility between microfluidic chips and biological reagents, miniaturized integration of POCT microfluidic systems, and performance verification. He led the team to develop various types of microfluidic chips and their related detection systems, achieving tremendous commercial success.

a senior expert in the blood testing direction of the IVD industry, has over ten years of frontline and management experience in the IVD industry, as well as blood testing technology R&D, reagent product transformation, and clinical blood testing. He is proficient in core skills such as blood testing reagent formula R&D and blood sample pretreatment technology, and focuses on the verification of specificity and sensitivity of blood testing reagents, R&D of blood POCT rapid detection products, and adaptability research between blood testing and clinical disease diagnosis. He is familiar with global IVD product registration regulations including NMPA/FDA/CE and clinical blood laboratory quality control standards (ISO 15189 special requirements for blood testing), and has rich experience in blood testing technology R&D and integration transformation of reagents and equipment.